Avanos Medical (AVNS) Gross Profit (2013 - 2026)

Avanos Medical has disclosed Gross Profit across 14 years of filings, most recently posting $94.2 million for Q1 2026.

• Gross Profit for Q1 2026 came in at $94.2 million, up 4.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $358.3 million (down 4.78% YoY), and the FY2025 annual result was $353.9 million, down 7.19% from the prior year.
• Gross Profit came in at $94.2 million for Q1 2026 at Avanos Medical, up from $86.0 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $106.6 million in Q1 2022 to a low of $86.0 million in Q3 2025.
• The 5-year median for Gross Profit is $95.0 million (2023), against an average of $95.3 million.
• Across the five-year window, Gross Profit soared 218.58% in 2022 and fell 14.26% in 2023, its largest moves.
• Avanos Medical's Gross Profit stood at $102.9 million in 2022, then retreated by 7.68% to $95.0 million in 2023, then gained by 3.16% to $98.0 million in 2024, then slipped by 12.24% to $86.0 million in 2025, then gained by 9.53% to $94.2 million in 2026.
• The last three Gross Profit figures came in at $94.2 million (Q1 2026), $86.0 million (Q4 2025), and $86.0 million (Q3 2025), per Business Quant data.